Pieris Pharmaceuticals, Inc.
Q3 2024 13F Holders
Symbol
PIRS
CUSIP
720795202
Type
Equity
Class
COM NEW
Num filers
26
Total reported value, excl. options
$10.1M
Compare 2024 Q3 to
2025 Q2
2024 Q2
Manager
Report Date
Value ($000)
Shares
Option Type